Samaneh Ghanbari

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 14

Top Topics

Mitochondrial Dna

Angiotensin Converting Enzyme

Top Venues

Applied microbiology and biotechnology

Biotechnology and bioengineering

This page only lists publications with an associated author ORCID identifier.

Publications

Shahin Amiri, Setare Adibzadeh, Samaneh Ghanbari, Behnaz Rahmani, Mohammad Hassan Kheirandish, Aref Farokhi-Fard, Mansoureh Shahbazi Dastjerdeh, Fatemeh Davami
CRISPR-interceded CHO cell line development approaches. Biotechnology and bioengineering 120 (4) (2023)
Shahin Amiri, Setare Adibzadeh, Samaneh Ghanbari, Behnaz Rahmani, Mohammad Hassan Kheirandish, Aref Farokhi-Fard, Mansoureh Shahbazi Dastjerdeh, Fatemeh Davami
CRISPR-interceded CHO cell line development approaches. Biotechnology and bioengineering 120 (4) (2023)
Shahin Amiri, Setare Adibzadeh, Samaneh Ghanbari, Behnaz Rahmani, Mohammad Hassan Kheirandish, Aref Farokhi-Fard, Mansoureh Shahbazi Dastjerdeh, Fatemeh Davami
CRISPR-interceded CHO Cell Line Development approaches. Biotechnology and bioengineering (2023)
Shahin Amiri, Setare Adibzadeh, Samaneh Ghanbari, Behnaz Rahmani, Mohammad Hassan Kheirandish, Aref Farokhi-Fard, Mansoureh Shahbazi Dastjerdeh, Fatemeh Davami
CRISPR-interceded CHO cell line development approaches. Biotechnology and bioengineering 120 (4) (2023)
Shahin Amiri, Setare Adibzadeh, Samaneh Ghanbari, Behnaz Rahmani, Mohammad Hassan Kheirandish, Aref Farokhi-Fard, Mansoureh Shahbazi Dastjerdeh, Fatemeh Davami
CRISPR-interceded CHO cell line development approaches. Biotechnology and bioengineering 120 (4) (2023)
Shahin Amiri, Setare Adibzadeh, Samaneh Ghanbari, Behnaz Rahmani, Mohammad Hassan Kheirandish, Aref Farokhi-Fard, Mansoureh Shahbazi Dastjerdeh, Fatemeh Davami
CRISPR-interceded CHO cell line development approaches. Biotechnology and bioengineering (2023)
Samaneh Ghanbari, Elham Bayat, Masoumeh Azizi, Pezhman Fard-Esfahani, Mohammad Hossein Modarressi, Fatemeh Davami
Targeted integration in CHO cells using CRIS-PITCh/Bxb1 recombinase-mediated cassette exchange hybrid system. Applied microbiology and biotechnology 107 (2-3) (2022)
Samaneh Ghanbari, Elham Bayat, Masoumeh Azizi, Pezhman Fard-Esfahani, Mohammad Hossein Modarressi, Fatemeh Davami
Targeted integration in CHO cells using CRIS-PITCh/Bxb1 recombinase-mediated cassette exchange hybrid system. Applied microbiology and biotechnology (2022)
Samaneh Ghanbari, Elham Bayat, Masoumeh Azizi, Pezhman Fard-Esfahani, Mohammad Hossein Modarressi, Fatemeh Davami
Targeted integration in CHO cells using CRIS-PITCh/Bxb1 recombinase-mediated cassette exchange hybrid system. Applied microbiology and biotechnology (2022)
Samaneh Ghanbari, Elham Bayat, Masoumeh Azizi, Pezhman Fard-Esfahani, Mohammad Hossein Modarressi, Fatemeh Davami
Targeted integration in CHO cells using CRIS-PITCh/Bxb1 recombinase-mediated cassette exchange hybrid system. Applied microbiology and biotechnology 107 (2-3) (2022)
Samaneh Ghanbari, Elham Bayat, Masoumeh Azizi, Pezhman Fard-Esfahani, Mohammad Hossein Modarressi, Fatemeh Davami
Targeted integration in CHO cells using CRIS-PITCh/Bxb1 recombinase-mediated cassette exchange hybrid system. Applied microbiology and biotechnology (2022)
Samaneh Ghanbari, Elham Bayat, Masoumeh Azizi, Pezhman Fard-Esfahani, Mohammad Hossein Modarressi, Fatemeh Davami
Targeted integration in CHO cells using CRIS-PITCh/Bxb1 recombinase-mediated cassette exchange hybrid system. Applied microbiology and biotechnology 107 (2-3) (2022)
Samaneh Ghanbari, Elham Bayat, Masoumeh Azizi, Pezhman Fard-Esfahani, Mohammad Hossein Modarressi, Fatemeh Davami
Targeted integration in CHO cells using CRIS-PITCh/Bxb1 recombinase-mediated cassette exchange hybrid system. Applied microbiology and biotechnology (2022)
Samaneh Ghanbari, Elham Bayat, Masoumeh Azizi, Pezhman Fard-Esfahani, Mohammad Hossein Modarressi, Fatemeh Davami
Targeted integration in CHO cells using CRIS-PITCh/Bxb1 recombinase-mediated cassette exchange hybrid system. Applied microbiology and biotechnology (2022)